Biotechnology Value Trading Fund OS LP

Director, See Remarks and Footnotes · Kymera Therapeutics, Inc.

Every open-market stock purchase Biotechnology Value Trading Fund OS LP has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought

$14.0M

Open-market buys

Companies

Last buy

Jun 30, 2025

Where the buys stand today

KYMR
Kymera Therapeutics, Inc.
+160.8% vs price paid
3 purchases totalling $14.0M at an average of $44.00 per share; the stock last traded at $114.76. See all insider buying in KYMR →
Avg price paid
$44.00
Latest price
$114.76
Market cap
$9.4B

Cluster participation

Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.

KYMRJun 30 – Jun 30, 2025
2 insiders$42.8M

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Jun 30, 2025	KYMRcluster	58,780	$44.00	$2.6M	SEC ↗
Jun 30, 2025	KYMRcluster	115,783	$44.00	$5.1M	SEC ↗
Jun 30, 2025	KYMRcluster	142,604	$44.00	$6.3M	SEC ↗

Follow new qualifying clusters involving Biotechnology Value Trading Fund OS LP or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Biotechnology Value Trading Fund OS LP's Form 4 filings on SEC EDGAR (CIK 1660683) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.